Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study
暂无分享,去创建一个
I. James | F. Christiansen | F. Mastaglia | A. Kermode | W. Carroll | A. Castley | Jingshan Wu | Wei Qiu
[1] I. James,et al. Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia , 2010, Multiple sclerosis.
[2] M. Pinto-Medel,et al. HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain) , 2009, Journal of Neurology.
[3] T. Kilpatrick,et al. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. , 2009, Tissue antigens.
[4] Sreeram V Ramagopalan,et al. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility , 2009, Proceedings of the National Academy of Sciences.
[5] G. Ebers,et al. Epistasis , 2009, Neurology.
[6] S. Baranzini,et al. Uncoupling the Roles of HLA-DRB1 and HLA-DRB5 Genes in Multiple Sclerosis1 , 2008, The Journal of Immunology.
[7] A. Montpetit,et al. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility , 2008, Proceedings of the National Academy of Sciences.
[8] Arne Svejgaard,et al. The immunogenetics of multiple sclerosis , 2008, Immunogenetics.
[9] A. Kermode,et al. Characterisation of the spectrum of demyelinating disease in Western Australia , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[10] David Heckerman,et al. Statistical Resolution of Ambiguous HLA Typing Data , 2008, PLoS Comput. Biol..
[11] A. Verma,et al. Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study , 2008 .
[12] D. Williamson,et al. HLA-DR15 haplotype and multiple sclerosis: a HuGE review. , 2007, American journal of epidemiology.
[13] J. Bell,et al. Parental transmission of HLA-DRB1*15 in multiple sclerosis , 2007, Human Genetics.
[14] Pablo Villoslada,et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. , 2006, Human molecular genetics.
[15] Vincent Ferretti,et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis , 2005, Nature Genetics.
[16] M. Z. Cader,et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. , 2005, Human molecular genetics.
[17] G. Salemi,et al. Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity , 2005, Neurology.
[18] F. Guerini,et al. HLA–multiple sclerosis association in Continental Italy and correlation with disease prevalence in Europe , 2004, Journal of Neuroimmunology.
[19] S. Sawcer,et al. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis , 2002, Journal of neurology, neurosurgery, and psychiatry.
[20] F. Cucca,et al. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. , 2001, Human molecular genetics.
[21] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[22] F. Christiansen,et al. HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors. , 2001, Tissue antigens.
[23] J. Hillert,et al. HLA‐DR15 is associated with lower age at onset in multiple sclerosis , 2000, Annals of neurology.
[24] Z. Meiner,et al. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. , 1999, Archives of neurology.
[25] F. Muntoni,et al. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. , 1998, Human molecular genetics.
[26] T. Welborn. The Busselton Study. Mapping population health. Cardiovascular and respiratory diseasea risk factors , 1998 .
[27] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.